C
Pediatrix Medical Group, Inc. MD
$23.66 $1.195.30% NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

03/31/2026 12/31/2025 09/30/2025 06/30/2025 03/31/2025
Net Income 174.22M 165.39M 162.19M 109.92M -82.37M
Total Depreciation and Amortization 22.61M 21.83M 23.07M 23.77M 27.25M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 47.98M 42.05M 22.75M 39.21M 191.25M
Change in Net Operating Assets 13.89M 41.83M 82.00M 71.66M 78.20M
Cash from Operations 258.71M 271.09M 290.00M 244.55M 214.34M
Capital Expenditure -21.39M -18.46M -16.61M -17.56M -20.01M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -30.20M -23.20M -19.20M 0.00 0.00
Divestitures 30.00M 30.00M 30.00M -- --
Other Investing Activities -1.23M -6.64M -4.15M -3.33M -6.62M
Cash from Investing -22.81M -18.30M -9.95M -20.89M -26.63M
Total Debt Issued -- -- 0.00 0.00 65.00M
Total Debt Repaid -22.45M -20.75M -19.38M -17.97M -161.60M
Issuance of Common Stock 3.07M 3.18M 3.27M 3.47M 3.44M
Repurchase of Common Stock -106.57M -86.68M -23.29M -2.58M -2.39M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -3.14M -3.25M -4.42M -1.25M -1.18M
Cash from Financing -129.09M -107.49M -43.82M -18.33M -96.72M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 106.80M 145.30M 236.23M 205.33M 90.98M